Elizabeth P. Bhatt
President & COOMs. Elizabeth P. Bhatt, also known as Liz, M.S., M.B.A. is the Chief Operating Officer of Septerna, Inc. from June 15, 2022 and as its President from August 1, 2025. She had served as Chief Business and Strategy Officer at Applied Molecular Transport Inc., since September 2019 until May 2022. Ms. Bhatt served as an Independent Director at eFFECTOR Therapeutics, Inc. since January 2021 until June 21, 2024. She has been Consultant of Achaogen, Inc., since June 30, 2019. Ms. Bhatt served as the Chief Business Officer of Achaogen, Inc., since September 18, 2017 until June 30, 2019 and served as its Chief Operating Officer since July 26, 2018 until June 30, 2019. Ms. Bhatt has experience in corporate development and strategy in the biopharmaceutical industry. Most recently, Ms. Bhatt served as Vice President of Corporate Development at Gilead Sciences from January 2016 to September 2017, where she was responsible for executing licenses, acquisitions and collaborations across all of Gilead’s therapeutic areas. She served as Senior Director of Corporate Development at Gilead Sciences from May 2011 to December 2015. While at Gilead, she also led long-term global commercial and strategic planning for Gilead’s antiviral and respiratory franchises. Before Gilead, Ms. Bhatt held corporate development and strategy roles at Eli Lilly and Maxygen, Inc. She started her career in research at Affymax. Ms. Bhatt earned a B.A. in Chemistry from Pomona College, an M.S. in Biomedical Sciences from the University of California at San Diego and an M.B.A. from the Kellogg School of Management at Northwestern University.
Positions
- Company NameSepterna, Inc.Stock CodeSEPNPositionPresident & COOColleagues
- JTJeffrey T. FinerCo-Founder, CEO & Director
- JKJeffrey K. TongChairman of the Board
- GMGilbert M. LabrucherieChief Financial Officer
- RJRobert J. LefkowitzCo-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board
- ACArthur ChristopoulosCo-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board
- PSPatrick SextonCo-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board
